World's Best Scientists 2026 revealed!
Henry G. Grabowski

Henry G. Grabowski

D-Index & Metrics

Economics and Finance

D-Index
51
Citations
21036
World Ranking
1291
National Ranking
780

Overview

Henry G. Grabowski is affiliated with Duke University in the United States and specializes in research within the fields of Economics, Econometrics and Finance. The primary subfields of their work include Economics and Econometrics, Pharmacology, and Pulmonary and Respiratory Medicine.

The scientist's research topics focus extensively on Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, and Quality of Life issues. Additional areas of study cover the Pharmaceutical industry and healthcare, Economic and Financial Impacts of Cancer, Innovation Policy and R&D, as well as Cystic Fibrosis Research Advances.

Henry G. Grabowski has published articles in several academic journals with a notable concentration in the Journal of Medical Economics and Health Affairs, as well as a contribution to the Journal of Cystic Fibrosis. The recent publications include:

  • "Continuing trends in U.S. brand-name and generic drug competition", 2021, Journal of Medical Economics
  • "Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act", 2024, Health Affairs
  • "Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act", 2024, Journal of Medical Economics
  • "Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerations", 2024, Journal of Medical Economics (co-authored)
  • "503 Perceptions of treatment burden for people with cystic fibrosis on highly effective modulator therapy after a withdrawal study", 2023, Journal of Cystic Fibrosis (co-authored)

Collaboration plays a role in their research, with frequent co-authors including Genia Long (4 publications), Joseph A. DiMasi (2 publications), Richard Mortimer, Mehmet Bilginsoy, and David Proudman, the latter three contributing to at least one publication each.

The scope of Henry G. Grabowski's work centers on analyzing economic and policy implications in pharmaceutical sectors, particularly focusing on drug competition, innovation in oncology drugs, and regulatory impacts such as those related to the US Inflation Reduction Act. Their cross-disciplinary approach integrates economic evaluations with health system and disease-specific research including cystic fibrosis and cardiovascular drug trials.

Best Publications

  • The price of innovation: new estimates of drug development costs

    Joseph A. DiMasi;Ronald W. Hansen;Henry G. Grabowski

  • Innovation in the pharmaceutical industry: New estimates of R&D costs

    Joseph A. DiMasi;Henry G. Grabowski;Ronald W. Hansen

  • Cost of innovation in the pharmaceutical industry.

    Joseph A DiMasi;Ronald W Hansen;Henry G Grabowski;Louis Lasagna

  • The cost of biopharmaceutical R&D: is biotech different?

    Joseph A. DiMasi;Henry G. Grabowski

  • Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act

    Henry G. Grabowski;John M. Vernon

  • A New Look at the Returns and Risks to Pharmaceutical R&D

    Henry Grabowski;John Vernon

  • Economics of New Oncology Drug Development

    Joseph A. DiMasi;Henry G. Grabowski

  • Returns on Research and Development for 1990s New Drug Introductions

    Henry Grabowski;John Vernon;Joseph A. DiMasi

  • Industrial Research and Development, Intangible Capital Stocks, and Firm Profit Rates

    Henry G. Grabowski;Dennis C. Mueller

  • Returns to R&D on new drug introductions in the 1980s

    Henry G Grabowski;John M Vernon

  • The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries

    Unknown

  • Developing Drugs For Developing Countries

    David B. Ridley;Henry G. Grabowski;Jeffrey L. Moe

  • Generic competition and market exclusivity periods in pharmaceuticals

    Henry G. Grabowski;Margaret Kyle

  • Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program

    Jennifer S. Li;Eric L. Eisenstein;Henry G. Grabowski;Elizabeth D. Reid

  • Managerial and Stockholder Welfare Models of Firm Expenditures

    Henry G. Grabowski;Dennis C. Mueller

  • Longer patents for increased generic competition in the US. The Waxman-Hatch Act after one decade.

    Henry Grabowski;John Vernon

  • Patents, Innovation and Access to New Pharmaceuticals

    Henry Grabowski

  • Generic Competition in the US Pharmaceutical Industry

    Atanu Saha;Henry Grabowski;Howard Birnbaum;Paul Greenberg

  • Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

    Joseph A. DiMasi;Ronald W. Hansen;Henry C. Grabowski;Louis Lasagna

  • International public goods and transfer of technology under a globalized intellectual property regime

    Keith E. Maskus;Jerome H. Reichman

  • Estimating the effects of regulation on innovation: an international comparative analysis of the pharmaceutical industry.

    Henry G. Grabowski;John M. Vernon;Lacy Glenn Thomas

  • R&D Costs and Returns by Therapeutic Category

    Joseph A DiMasi;Henry G Grabowski;John M Vernon

  • The determinants of pharmaceutical research and development expenditures

    Henry Grabowski;John Vernon

Frequent Co-Authors

Dennis C. Mueller
Dennis C. Mueller University of Vienna
Frank A. Sloan
Frank A. Sloan Duke University
Gary A. Zarkin
Gary A. Zarkin Research Triangle Park Foundation
W. Kip Viscusi
W. Kip Viscusi Vanderbilt University
Tracy R. Lewis
Tracy R. Lewis Duke University
William N. Evans
William N. Evans University of Notre Dame
Iain M. Cockburn
Iain M. Cockburn Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Economics and Finance opens doors to a variety of career paths, and many students explore related fields through online programs for greater flexibility and affordability. For those interested in management roles within the hospitality sector, a fast track hospitality management degree can be an efficient way to gain industry-specific leadership skills.

If you're seeking advanced business knowledge, consider enrolling in affordable aacsb-accredited online mba programs. These programs are recognized for their quality and can significantly enhance your career prospects in both finance and broader business environments.

Human resource management is another field closely tied to finance and organizational success. The best hr master's programs online help build skills in workforce planning, talent management, and employee relations—expertise in high demand across industries.

Finally, clear communication is essential in both economics and finance. A masters in communication online can provide advanced strategies for conveying complex ideas and reports, supporting leadership roles in financial organizations.

Best Scientists Citing Henry G. Grabowski

Trending Scientists

Recently Published Articles